Search bioRxivSearch

bioRxiv · 10.1101/2020.02.28.969170

Understanding biochemical design principles with ensembles of canonical non-linear models

Abstract

Systems biology applies concepts from engineering in order to understand biological networks. If such an understanding was complete, biologists would be able to design ad hoc biochemical components tailored for different purposes, which is the goal of synthetic biology. Needless to say that we are far away from creating biological subsystems as intricate and precise as those found in nature, but mathematical models and high throughput techniques have brought us a long way in this direction. One of the difficulties that still needs to be overcome is finding the right values for model parameters and dealing with uncertainty, which is proving to be an extremely difficult task. In this work, we take advantage of ensemble modeling techniques, where a large number of models with different parameter values are formulated and then tested according to some performance criteria. By finding features shared by successful models, the role of different components and the synergies between them can be better understood. We will address some of the difficulties often faced by ensemble modeling approaches, such as the need to sample a space whose size grows exponentially with the number of parameters, and establishing useful selection criteria. Some methods will be shown to reduce the predictions from many models into a set of understandable "design principles" that can guide us to improve or manufacture a biochemical network. Our proposed framework formulates models within standard formalisms in order to integrate information from different sources and minimize the dimension of the parameter space. Additionally, the mathematical properties of the formalism enable a partition of the parameter space into independent subspaces. Each of these subspaces can be paired with a set of criteria that depend exclusively on it, thus allowing a separate sampling/screening in spaces of lower dimension. By applying tests in a strict order where computationally cheaper tests are applied first to each subspace and applying computationally expensive tests to the remaining subset thereafter, the use of resources is optimized and a larger number of models can be examined. This can be compared to a complex database query where the order of the requests can make a huge difference in the processing time. The method will be illustrated by analyzing a classical model of a metabolic pathway with end-product inhibition. Even for such a simple model, the method provides novel insight. Author summaryA method is presented for the discovery of design principles, understood as recurrent solutions to evolutionary problems, in biochemical networks. The method takes advantage of ensemble modeling techniques, where a large number of models with different parameter values are formulated and then tested according to some performance criteria. By finding features shared by successful models, a set of simple rules can be identified that enables us to formulate new models that are known to perform well, a priori. By formulating the models within the framework of Biochemical Systems Theory (BST) we manage to overcome some of the obstacles often faced by ensemble modeling. Further analysis of the selected modeling with standard machine learning techniques enables the formulation of simple rules - design principles - for building good performing networks. We illustrate the method with a well-known case study: the unbranched pathway with end-product inhibition. The method manages to identify the known features of this well-studied pathway while providing additional guidelines on how the pathway kinetics can be tuned to achieve a desired functionality - e.g. demand vs supply control - as well as to identifying important tradeoffs between performance, robustness and and stability.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bromig, L., Kremling, A., Marin-Sanguino, A.. 2020-02-29. Understanding biochemical design principles with ensembles of canonical non-linear models. https://doi.org/10.1101/2020.02.28.969170

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology